Share Liquidity

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Toinv

Rank: President [?]

Points: 4445 [?]

Votes: 35 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Share Liquidity

posted on Dec 17, 2017 12:06PM

For anyone who attended the Zenith AGM was there any discussion of share liquidity either in the presentation or during the Q & A?

My sense is that Zenith Epigenetics is only at the earlist stages of clinical trials. From what I have seen on these companies they tend to not have very high valuations. However, there are always exceptions.

Any thoughts or info?

Thanks

Toinv

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply